MC5004b : High-density multiple organs tumor with normal tissue array, including pathology grade, TNM and clinical stage, 500 cases/500 cores (core size 0.6mm), replacing MC5004a
|
Microarray Panel | High-density multiple organs tumor with normal tissue microarray, containing 20 types of human organs, each organ was taken from 25 individuals (20 cases of tumor and 5 normal tissue), single core per case | |
Cores | 500 | |
Cases | 500 | |
Row number | 20 | |
Column number | 25 | |
Core Diameter (mm) | 0.6 | |
Thickness (µm) | 5 | |
Quality Control | H&E and IHC confirmed | |
Tissue Array Type | FFPE | |
Species | Human | |
Notes | 1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours. In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers. |
Mouseover and click individual cores to view high resolution images.
Legend: | Arm - Arm,
Bil - Bilateral ovary,
Bla - Bladder,
Bre - Breast,
Buc - Buccal,
Car - Cardia,
Cer - Cervix,
Che - Chest wall,
Col - Colon,
Eso - Esophagus,
Gin - Gingiva,
Gro - Groin,
Ile - Ileocecal part,
Kid - Kidney,
Lef - Left buccal,
Liv - Liver,
Low - Lower lip,
Lun - Lung,
Lym - Lymph node,
Max - Maxillary sinus,
Ova - Ovary,
Pan - Pancreas,
Par - Parotid gland,
Pro - Prostate,
Rec - Rectum,
Rig - Right submaxillary,
Sal - Salivary gland,
Sig - Sigmoid colon,
Sin - Sinuses,
Ske - Skeletal muscle,
Ski - Skin,
Sof - Soft tissue/Chest wall ,
Sto - Stomach,
Tes - Testis,
Thi - Thigh,
Thy - Thyroid gland,
Ton - Tongue,
Ute - Uterus,
Wai - Waist
|
Specification Sheet (Sortable), tissue IDs are available in exported Excel files.
Pos. | No. | Age | Sex | Organ/Anatomic Site | Pathology diagnosis | TNM | Grade | Stage | Type | Image |
---|
A1 | 1 | 55 | M | Stomach | Adenocarcinoma | T4N2M0 | 2 | IV | Malignant | |
A2 | 2 | 48 | F | Stomach | Adenocarcinoma | T3N2M0 | 3 | IIIA | Malignant | |
A3 | 3 | 64 | M | Stomach | Adenocarcinoma | T2N1M0 | 2 | IIA | Malignant | |
A4 | 4 | 60 | M | Stomach | Adenocarcinoma | T4N0M0 | 2 | IIA | Malignant | |
A5 | 5 | 57 | M | Stomach | Adenocarcinoma | T3N0M0 | 2 | IIA | Malignant | |
A6 | 6 | 74 | F | Skin/Back | Malignant melanoma | T4aN0M0 | - | IIB | Malignant | |
A7 | 7 | 51 | M | Skin/Back | Malignant melanoma | T4aN0M0 | - | IIB | Malignant | |
A8 | 8 | 38 | F | Skin/Back | Malignant melanoma | T4N0M0 | - | IIB | Malignant | |
A9 | 9 | 52 | M | Skin/Lower abdominal wall | Malignant melanoma | T4bN0M0 | - | IIC | Malignant | |
A10 | 10 | 40 | M | Skin/Right chest wall | Malignant melanoma | T4bN0M0 | - | IIC | Malignant | |
A11 | 11 | 78 | M | Prostate | Adenocarcinoma (Gleason grade:1, Gleason score 3+2) | T2bN0M0 | 1 | IIA | Malignant | |
A12 | 12 | 66 | M | Prostate | Adenocarcinoma (Gleason grade:5, Gleason score 4+5) | T2N0M0 | 3 | IIC | Malignant | |
A13 | 13 | 75 | M | Prostate | Adenocarcinoma (Gleason grade:3, Gleason score 4+3) | T2N0M0 | 2 | IIB | Malignant | |
A14 | 14 | 69 | M | Prostate | Adenocarcinoma (Gleason grade:2, Gleason score 3+4) | T3N0M0 | 2 | IIIB | Malignant | |
A15 | 15 | 79 | M | Prostate | Adenocarcinoma (Gleason grade:4, Gleason score 4+4) | T2N0M0 | 3 | IIC | Malignant | |
A16 | 16 | 48 | M | Cerebrum/Right occipital lobe | Anaplastic astrocytoma | - | 3 | - | Malignant | |
A17 | 17 | 60 | M | Cerebrum/Right temporal lobe | Astrocytoma | - | 2 | - | Malignant | |
A18 | 18 | 66 | M | Cerebrum | Glioblastoma (GBM) | - | 4 | - | Malignant | |
A19 | 19 | 59 | M | Cerebrum/Temporal lobe | Astrocytoma | - | 2 | - | Malignant | |
A20 | 20 | 36 | F | Cerebrum/Right temporal lobe | Astrocytoma | - | 2 | - | Malignant | |
A21 | 21 | 49 | F | Ovary | High grade serous carcinoma | T3aN0M0 | - | IIIA | Malignant | |
A22 | 22 | 47 | F | Ovary | High grade serous carcinoma | T1N0M0 | - | I | Malignant | |
A23 | 23 | 46 | F | Ovary | High grade serous carcinoma | T3aN1M0 | - | IIIA2 | Malignant | |
A24 | 24 | 58 | F | Ovary | High grade serous carcinoma | T1N0M0 | - | I | Malignant | |
A25 | 25 | 57 | F | Bilateral ovary | High grade serous carcinoma | T3cN1M0 | - | IIIC | Malignant | |
B1 | 26 | 66 | M | Stomach | Adenocarcinoma | T3N0M0 | 2 | IIA | Malignant | |
B2 | 27 | 62 | F | Stomach | Adenocarcinoma | T4aN0M0 | 2 | IIB | Malignant | |
B3 | 28 | 49 | M | Cardia | Adenocarcinoma | T3N0M0 | 2 | IIA | Malignant | |
B4 | 29 | 78 | M | Stomach | Adenocarcinoma | T3N0M0 | 3 | IIA | Malignant | |
B5 | 30 | 46 | F | Stomach | Adenocarcinoma | T3N3aM0 | 3 | IIIB | Malignant | |
B6 | 31 | 37 | M | Skin/Right arm | Malignant melanoma | T4aN0M0 | - | IIB | Malignant | |
B7 | 32 | 41 | M | Skin/Forearm | Malignant melanoma | T4aN0M0 | - | IIB | Malignant | |
B8 | 33 | 60 | M | Skin/Right hip | Malignant melanoma | T4aN1M0 | - | III | Malignant | |
B9 | 34 | 46 | F | Skin/Thigh | Malignant melanoma | T4bN0M0 | - | IIC | Malignant | |
B10 | 35 | 25 | M | Skin/Left plantar | Malignant melanoma | T2N0M0 | - | I | Malignant | |
B11 | 36 | 75 | M | Prostate | Adenocarcinoma (Gleason grade:4, Gleason score 4+4) | T2aN0M0 | 2 | IIC | Malignant | |
B12 | 37 | 76 | M | Prostate | Adenocarcinoma (Gleason grade:3, Gleason score 4+3) | T2N0M0 | 2 | IIC | Malignant | |
B13 | 38 | 73 | M | Prostate | Adenocarcinoma (Gleason grade:2, Gleason score 3+4) | T2N0M0 | 2 | IIB | Malignant | |
B14 | 39 | 74 | M | Prostate | Adenocarcinoma (Gleason grade:3, Gleason score 4+3) | T2N0M0 | 2 | IIC | Malignant | |
B15 | 40 | 76 | M | Prostate | Adenocarcinoma (Gleason grade:2, Gleason score 3+4) | T3N0M0 | 2 | IIIB | Malignant | |
B16 | 41 | 32 | F | Cerebrum/Right frontal lobe | Anaplastic astrocytoma | - | 3 | - | Malignant | |
B17 | 42 | 56 | M | Cerebrum/Right temporal lobe | Glioblastoma (GBM) | - | 4 | - | Malignant | |
B18 | 43 | 33 | F | Cerebrum/Left temporal lobe | Glioblastoma (GBM) | - | 4 | - | Malignant | |
B19 | 44 | 41 | F | Cerebrum/Right temporal lobe | Astrocytoma | - | 2 | - | Malignant | |
B20 | 45 | 52 | M | Cerebrum/Right parietal lobe | Anaplastic astrocytoma | - | 3 | - | Malignant | |
B21 | 46 | 42 | F | Ovary | High grade serous carcinoma | T2N0M0 | - | II | Malignant | |
B22 | 47 | 51 | F | Ovary | Low grade serous carcinoma | T3cN1M0 | - | IIIC | Malignant | |
B23 | 48 | 34 | F | Ovary | Low grade serous carcinoma | T1aN0M0 | - | IA | Malignant | |
B24 | 49 | 38 | F | Ovary | Low grade serous carcinoma | T3cN1M0 | - | IIIC | Malignant | |
B25 | 50 | 26 | F | Ovary | Low grade serous carcinoma | T1cN0M0 | - | IC | Malignant | |
C1 | 51 | 56 | F | Stomach | Adenocarcinoma | T3N0M0 | 3 | IIA | Malignant | |
C2 | 52 | 53 | M | Stomach | Adenocarcinoma | T3N0M0 | 3 | IIA | Malignant | |
C3 | 53 | 46 | M | Stomach | Adenocarcinoma | T3N2M0 | 3 | IIIB | Malignant | |
C4 | 54 | 66 | M | Stomach | Adenocarcinoma | T3N0M0 | 3 | IIA | Malignant | |
C5 | 55 | 58 | M | Cardia | Adenocarcinoma | T3N0M0 | 3 | IIA | Malignant | |
C6 | 56 | 53 | M | Skin/Right plantar | Malignant melanoma | T4bN0M0 | - | IIC | Malignant | |
C7 | 57 | 18 | F | Skin/Left foot toe | Malignant melanoma | T1bN0M0 | - | IA | Malignant | |
C8 | 58 | 64 | M | Skin/Left heel | Malignant melanoma | T3bN3aM0 | - | IIIC | Malignant | |
C9 | 59 | 42 | M | Skin/Left heel | Malignant melanoma | T3aN0M0 | - | IIA | Malignant | |
C10 | 60 | 45 | M | Skin/Perianal | Malignant melanoma | T3bN0M0 | - | IIB | Malignant | |
C11 | 61 | 80 | M | Prostate | Adenocarcinoma (Gleason grade:3, Gleason score 4+3) | T2N0M0 | 2 | IIC | Malignant | |
C12 | 62 | 73 | M | Prostate | Adenocarcinoma (Gleason grade:5, Gleason score 4+5) | T2N0M0 | 3 | IIIC | Malignant | |
C13 | 63 | 65 | M | Prostate | Adenocarcinoma (Gleason grade 5, Gleason score 5+4) | T2bN0M0 | 3 | IIIC | Malignant | |
C14 | 64 | 64 | M | Prostate | Adenocarcinoma (Gleason grade:2, Gleason score 3+4) | T2N0M0 | 2 | IIB | Malignant | |
C15 | 65 | 75 | M | Prostate | Adenocarcinoma (Gleason grade:4, Gleason score 3+4) | T2aN0M0 | 2 | IIC | Malignant | |
C16 | 66 | 43 | M | Cerebrum | Glioblastoma (GBM) | - | 4 | - | Malignant | |
C17 | 67 | 31 | M | Cerebrum/Left parieto-occipital lobe | Glioblastoma (GBM) | - | 4 | - | Malignant | |
C18 | 68 | 50 | M | Cerebrum/Left parietal lobe | Glioblastoma (GBM) | - | 4 | - | Malignant | |
C19 | 69 | 39 | M | Cerebrum/Right temporal lobe | Glioblastoma (GBM) | - | 4 | - | Malignant | |
C20 | 70 | 34 | F | Cerebrum/Right frontal lobe | Astrocytoma | - | 2 | - | Malignant | |
C21 | 71 | 34 | F | Bilateral ovary | Low grade serous carcinoma | T1bN0M0 | - | IB | Malignant | |
C22 | 72 | 49 | F | Ovary | Mucinous adenocarcinoma | T1aN0M0 | 1 | IA | Malignant | |
C23 | 73 | 46 | F | Ovary | Mucinous adenocarcinoma | T1aN0M0 | 1 | IA | Malignant | |
C24 | 74 | 48 | F | Ovary | Mucinous adenocarcinoma | T1bN0M0 | 1 | IB | Malignant | |
C25 | 75 | 65 | F | Ovary | Low grade serous carcinoma | T2aN0M0 | - | IIA | Malignant | |
D1 | 76 | 69 | M | Stomach | Adenocarcinoma | T3N0M0 | 3 | IIA | Malignant | |
D2 | 77 | 53 | M | Stomach | Adenocarcinoma | T3N0M0 | 3 | IIA | Malignant | |
D3 | 78 | 55 | M | Stomach | Adenocarcinoma | T3N0M0 | 3 | IIA | Malignant | |
D4 | 79 | 43 | M | Stomach | Adenocarcinoma | T3N1M0 | 3 | IIB | Malignant | |
D5 | 80 | 77 | M | Stomach | Adenocarcinoma | T3N0M0 | 3 | IIA | Malignant | |
D6 | 81 | 42 | M | Skin/Perianal | Malignant melanoma | T3N0M0 | - | IIA | Malignant | |
D7 | 82 | 45 | M | Rectum/Anal canal | Malignant melanoma | T4bN3M0 | - | IIIC | Malignant | |
D8 | 83 | 52 | M | Rectum | Malignant melanoma | T4bN0M0 | - | IIC | Malignant | |
D9 | 84 | 84 | F | Skin/Perianal | Malignant melanoma | T4bN0M0 | - | IIC | Malignant | |
D10 | 85 | 65 | M | Skin/Scalp | Malignant melanoma | T4aN0M0 | - | IIB | Malignant | |
D11 | 86 | 74 | M | Prostate | Adenocarcinoma (Gleason grade:5, Gleason score 4+5) | T2N0M0 | 3 | IIIC | Malignant | |
D12 | 87 | 71 | M | Prostate | Adenocarcinoma (Gleason grade:5, Gleason score 4+5) | T3N0M0 | 3 | IIIC | Malignant | |
D13 | 88 | 57 | M | Prostate | Adenocarcinoma (Gleason grade:4, Gleason score 4+4) | T2N0M0 | 3 | IIIA | Malignant | |
D14 | 89 | 74 | M | Prostate | Adenocarcinoma (Gleason grade:5, Gleason score 4+5) | T2N0M0 | 3 | IIIC | Malignant | |
D15 | 90 | 51 | M | Prostate | Adenocarcinoma (Gleason grade:4, Gleason score 4+4) | T2N0M0 | 3 | IIIA | Malignant | |
D16 | 91 | 28 | M | Cerebrum/Left temporal lobe | Anaplastic astrocytoma | - | 3 | - | Malignant | |
D17 | 92 | 42 | F | Cerebrum | Astrocytoma | - | 2 | - | Malignant | |
D18 | 93 | 59 | M | Cerebrum/Left occipital lobe | Glioblastoma (GBM) | - | 4 | - | Malignant | |
D19 | 94 | 59 | F | Cerebrum/Right frontal lobe | Glioblastoma (GBM) | - | 4 | - | Malignant | |
D20 | 95 | 59 | M | Cerebrum/Left occipital lobe | Glioblastoma (GBM) | - | 4 | - | Malignant | |
D21 | 96 | 41 | F | Ovary | Mucinous adenocarcinoma | T1bN0M0 | 3 | IB | Malignant | |
D22 | 97 | 52 | F | Ovary | Mucinous adenocarcinoma | T1bN0M0 | 3 | IB | Malignant | |
D23 | 98 | 29 | F | Ovary | Mucinous adenocarcinoma | T3N0M0 | 2 | III | Malignant | |
D24 | 99 | 54 | F | Ovary | Mucinous adenocarcinoma | T3cN0M0 | 3 | IIIC | Malignant | |
D25 | 100 | 22 | F | Ovary | Yolk sac tumor/Endodermal sinus carcinoma | T1cN0M0 | - | IC | Malignant | |
E1 | 101 | 50 | F | Stomach | Stomach tissue | - | - | - | Normal | |
E2 | 102 | 21 | F | Stomach | Stomach tissue | - | - | - | Normal | |
E3 | 103 | 37 | F | Stomach | Stomach tissue (fibrous vessels) | - | * | - | Normal | |
E4 | 104 | 73 | M | Stomach | Stomach tissue | - | - | - | Normal | |
E5 | 105 | 63 | F | Stomach | Stomach tissue | - | - | - | Normal | |
E6 | 106 | 35 | M | Skin | Skin tissue | - | - | - | Normal | |
E7 | 107 | 23 | M | Skin | Skin tissue | - | - | - | Normal | |
E8 | 108 | 45 | M | Skin | Skin tissue | - | - | - | Normal | |
E9 | 109 | 25 | M | Skin | Skin tissue | - | - | - | Normal | |
E10 | 110 | 21 | M | Skin | Skin tissue | - | - | - | Normal | |
E11 | 111 | 45 | M | Prostate | Prostate tissue | - | - | - | Normal | |
E12 | 112 | 30 | M | Prostate | Prostate tissue | - | - | - | Normal | |
E13 | 113 | 31 | M | Prostate | Prostate tissue | - | - | - | Normal | |
E14 | 114 | 34 | M | Prostate | Prostate tissue | - | - | - | Normal | |
E15 | 115 | 35 | M | Prostate | Prostate tissue | - | - | - | Normal | |
E16 | 116 | 43 | M | Cerebrum | Cerebrum tissue | - | - | - | Normal | |
E17 | 117 | 46 | M | Cerebrum | Cerebrum tissue | - | - | - | Normal | |
E18 | 118 | 37 | M | Cerebrum | Cerebrum tissue | - | - | - | Normal | |
E19 | 119 | 47 | M | Cerebrum | Cerebrum tissue | - | - | - | Normal | |
E20 | 120 | 47 | M | Cerebrum | Cerebrum tissue | - | - | - | Normal | |
E21 | 121 | 49 | F | Ovary | Ovarian tissue | - | - | - | Normal | |
E22 | 122 | 47 | F | Ovary | Ovarian tissue | - | - | - | Normal | |
E23 | 123 | 55 | F | Ovary | Ovarian tissue | - | - | - | Normal | |
E24 | 124 | 46 | F | Ovary | Ovarian tissue | - | - | - | Normal | |
E25 | 125 | 44 | F | Ovary | Ovarian tissue | - | - | - | Normal | |
F1 | 126 | 68 | F | Breast | Invasive carcinoma of no special type | T2N0M0 | 2 | IIA | Malignant | |
F2 | 127 | 55 | F | Breast | Invasive carcinoma of no special type | T2N0M0 | 2 | IIA | Malignant | |
F3 | 128 | 43 | F | Breast | Invasive carcinoma of no special type | T3N0M0 | 2 | IIB | Malignant | |
F4 | 129 | 47 | F | Breast | Invasive carcinoma of no special type | T3N1M0 | 2 | IIIA | Malignant | |
F5 | 130 | 77 | F | Breast | Invasive carcinoma of no special type | T2N0M0 | 2 | IIA | Malignant | |
F6 | 131 | 30 | M | Testis | Embryonal carcinoma | T2N0M0 | - | I | Malignant | |
F7 | 132 | 28 | M | Testis | Embryonal carcinoma | T1bN0M0 | - | I | Malignant | |
F8 | 133 | 23 | M | Testis | Embryonal carcinoma | T1N0M0 | - | I | Malignant | |
F9 | 134 | 21 | M | Testis | Embryonal carcinoma | T1bN0M0 | - | I | Malignant | |
F10 | 135 | 61 | M | Testis | Seminoma | T2N0M0 | - | I | Malignant | |
F11 | 136 | 57 | M | Colon | Papillary adenocarcinoma | T2N0M0 | 1 | I | Malignant | |
F12 | 137 | 62 | F | Colon | Tubular adenocarcinoma | T4N0M0 | 1 | IIB | Malignant | |
F13 | 138 | 58 | M | Colon | Adenocarcinoma | T3N1M0 | 2 | IIIB | Malignant | |
F14 | 139 | 65 | F | Colon | Papillary adenocarcinoma | T3N0M0 | 1 | IIA | Malignant | |
F15 | 140 | 69 | F | Colon | Adenocarcinoma | T31bN0M0 | 2 | IIIB | Malignant | |
F16 | 141 | 64 | M | Bladder | High grade invasive urothelial carcinoma | T1bN0M0 | - | IB | Malignant | |
F17 | 142 | 73 | M | Bladder | High grade invasive urothelial carcinoma | T3aN0M0 | - | IIIA | Malignant | |
F18 | 143 | 60 | F | Bladder | High grade invasive urothelial carcinoma | T3aN0M0 | - | IIIA | Malignant | |
F19 | 144 | 40 | M | Bladder | High grade invasive urothelial carcinoma | T2bN0M0 | - | II | Malignant | |
F20 | 145 | 58 | F | Bladder | High grade invasive urothelial carcinoma | T2aN0M0 | - | II | Malignant | |
F21 | 146 | 61 | F | Uterus | Endometrial adenocarcinoma | T1aN0M0 | 1 | IA | Malignant | |
F22 | 147 | 66 | F | Uterus | Endometrial adenocarcinoma | T1N0M0 | 1 | I | Malignant | |
F23 | 148 | 51 | F | Uterus | Endometrial adenocarcinoma | T1bN0M0 | 1 | IB | Malignant | |
F24 | 149 | 48 | F | Uterus | Endometrial adenocarcinoma | T1bN0M0 | 2 | IB | Malignant | |
F25 | 150 | 42 | F | Uterus | Endometrial adenocarcinoma | T1bN0M0 | 1 | IB | Malignant | |
G1 | 151 | 46 | F | Breast | Invasive carcinoma of no special type | T3N0M0 | 2 | IIB | Malignant | |
G2 | 152 | 47 | F | Breast | Invasive carcinoma of no special type | T2N1M0 | 2 | IIB | Malignant | |
G3 | 153 | 54 | F | Breast | Invasive carcinoma of no special type | T2N0M0 | 2 | IIA | Malignant | |
G4 | 154 | 49 | F | Breast | Invasive carcinoma of no special type | T2N2M0 | 2 | IIIA | Malignant | |
G5 | 155 | 49 | F | Breast | Invasive carcinoma of no special type | T2N0M0 | 2 | IIA | Malignant | |
G6 | 156 | 30 | M | Testis | Seminoma | T1N0M0 | - | IA | Malignant | |
G7 | 157 | 55 | M | Testis | Seminoma | T1N0M0 | - | I | Malignant | |
G8 | 158 | 70 | M | Testis | Seminoma | T1N0M0 | - | I | Malignant | |
G9 | 159 | 39 | M | Testis | Seminoma | T2N0M0 | - | IB | Malignant | |
G10 | 160 | 55 | M | Testis | Seminoma | T2N0M0 | - | IB | Malignant | |
G11 | 161 | 56 | F | Colon | Adenocarcinoma | T4aN0M0 | 2 | IIB | Malignant | |
G12 | 162 | 57 | F | Colon | Adenocarcinoma | T3N0M0 | 2 | IIA | Malignant | |
G13 | 163 | 60 | M | Sigmoid colon | Adenocarcinoma | T3N0M0 | 2 | IIA | Malignant | |
G14 | 164 | 68 | M | Colon | Adenocarcinoma | T4aN0M0 | 2 | IIB | Malignant | |
G15 | 165 | 49 | F | Colon | Adenocarcinoma | T4aN0M0 | 2 | IIB | Malignant | |
G16 | 166 | 64 | F | Bladder | Low grade invasive urothelial carcinoma | T2aN0M0 | - | II | Malignant | |
G17 | 167 | 42 | M | Bladder | High grade invasive urothelial carcinoma | T2aN0M0 | - | II | Malignant | |
G18 | 168 | 76 | M | Bladder | High grade invasive urothelial carcinoma | T3aN0M0 | - | III | Malignant | |
G19 | 169 | 65 | F | Bladder | High grade invasive urothelial carcinoma | T3N0M0 | - | III | Malignant | |
G20 | 170 | 51 | F | Bladder | High grade invasive urothelial carcinoma | T2bN0M0 | - | II | Malignant | |
G21 | 171 | 42 | F | Uterus | Endometrial adenocarcinoma | T2bN0M0 | 1 | IB | Malignant | |
G22 | 172 | 48 | F | Uterus | Endometrial adenocarcinoma | T1bN0M0 | 2 | IB | Malignant | |
G23 | 173 | 71 | F | Uterus | Endometrial adenocarcinoma | T1bN0M0 | 2 | IB | Malignant | |
G24 | 174 | 53 | F | Uterus | Endometrial adenocarcinoma | T1bN0M0 | 2 | IB | Malignant | |
G25 | 175 | 54 | F | Uterus | Endometrial adenocarcinoma | T1bN0M0 | 2 | IB | Malignant | |
H1 | 176 | 64 | F | Breast | Invasive carcinoma of no special type | T2N0M0 | 2 | IIA | Malignant | |
H2 | 177 | 53 | F | Breast | Invasive carcinoma of no special type | T2N0M0 | 2 | IIA | Malignant | |
H3 | 178 | 34 | F | Breast | Invasive carcinoma of no special type | T2N0M0 | 2 | IIA | Malignant | |
H4 | 179 | 45 | F | Breast | Invasive carcinoma of no special type | T2N0M0 | 2 | IIA | Malignant | |
H5 | 180 | 52 | F | Breast | Invasive carcinoma of no special type | T3N0M0 | 2 | IIB | Malignant | |
H6 | 181 | 36 | M | Testis | Seminoma | T2N0M0 | - | IB | Malignant | |
H7 | 182 | 40 | M | Testis | Seminoma | T1bN0M0 | - | IA | Malignant | |
H8 | 183 | 45 | M | Testis | Seminoma | T2N0M0 | - | IB | Malignant | |
H9 | 184 | 31 | M | Testis | Seminoma | T2N0M0 | - | IB | Malignant | |
H10 | 185 | 35 | M | Testis | Seminoma | T4N0M0 | - | IB | Malignant | |
H11 | 186 | 66 | M | Colon | Adenocarcinoma | T3N0M0 | 2 | IIA | Malignant | |
H12 | 187 | 62 | F | Colon | Adenocarcinoma | T4N0M0 | 2 | IIB | Malignant | |
H13 | 188 | 53 | M | Colon | Mucinous adenocarcinoma | T3N0M0 | 2 | IIA | Malignant | |
H14 | 189 | 43 | F | Colon | Adenocarcinoma | T4aN0M0 | 2 | IIB | Malignant | |
H15 | 190 | 72 | F | Ileocecal part | Adenocarcinoma | T4N1M0 | 2 | III | Malignant | |
H16 | 191 | 56 | M | Bladder | Low grade invasive urothelial carcinoma | T1N0M0 | - | I | Malignant | |
H17 | 192 | 61 | F | Bladder | High grade invasive urothelial carcinoma | T3aN0M0 | - | IIIA | Malignant | |
H18 | 193 | 66 | M | Bladder | Low grade invasive urothelial carcinoma | T1N0M0 | - | I | Malignant | |
H19 | 194 | 70 | F | Bladder | Low grade invasive urothelial carcinoma | T3aN0M0 | - | IIIA | Malignant | |
H20 | 195 | 72 | F | Bladder | Low grade invasive urothelial carcinoma | T1N0M0 | - | I | Malignant | |
H21 | 196 | 65 | F | Uterus | Endometrial adenocarcinoma | T3aN0M0 | 2 | IIIA | Malignant | |
H22 | 197 | 55 | F | Uterus | Endometrial adenocarcinoma | T1bN0M0 | 2 | IB | Malignant | |
H23 | 198 | 77 | F | Uterus | Endometrial adenocarcinoma | T1bN0M0 | 2 | IB | Malignant | |
H24 | 199 | 61 | F | Uterus | Endometrial adenocarcinoma | T1bN0M0 | 1 | IB | Malignant | |
H25 | 200 | 43 | F | Uterus | Endometrial adenocarcinoma | T1aN0M0 | 3 | IA | Malignant | |
I1 | 201 | 63 | F | Breast | Invasive carcinoma of no special type | T2N0M0 | 2 | IIA | Malignant | |
I2 | 202 | 57 | F | Breast | Invasive carcinoma of no special type | T4N0M0 | 2 | IIIB | Malignant | |
I3 | 203 | 69 | F | Breast | Invasive carcinoma of no special type | T3N1M0 | 2 | IIIA | Malignant | |
I4 | 204 | 51 | F | Breast | Invasive carcinoma of no special type | T3N0M0 | 2 | IIB | Malignant | |
I5 | 205 | 39 | F | Breast | Invasive carcinoma of no special type | T2N2M0 | 3 | IIIA | Malignant | |
I6 | 206 | 33 | M | Testis | Seminoma | T1N0M0 | - | I | Malignant | |
I7 | 207 | 34 | M | Testis | Seminoma | T1bN0M0 | - | IA | Malignant | |
I8 | 208 | 52 | M | Testis | Seminoma | T2N0M0 | - | I | Malignant | |
I9 | 209 | 39 | M | Testis | Mixed germ cell tumor | T1N0M0 | - | I | Malignant | |
I10 | 210 | 30 | M | Testis | Mixed carcinoma | T1N0M0 | - | I | Malignant | |
I11 | 211 | 35 | M | Colon | Adenocarcinoma | T4N1M0 | 2 | IIIB | Malignant | |
I12 | 212 | 55 | F | Ileocecal part | Adenocarcinoma | T3N1M0 | 2 | IIIB | Malignant | |
I13 | 213 | 48 | M | Colon | Adenocarcinoma | T2N1M0 | 3 | IIIA | Malignant | |
I14 | 214 | 47 | F | Colon | Adenocarcinoma | T3N2aN0 | 3 | IIIB | Malignant | |
I15 | 215 | 43 | F | Colon | Adenocarcinoma | T3N1M0 | 3 | IIIB | Malignant | |
I16 | 216 | 58 | M | Bladder | High grade invasive urothelial carcinoma | T2bN0M0 | - | II | Malignant | |
I17 | 217 | 57 | M | Bladder | Low grade invasive urothelial carcinoma | T1N0M0 | - | I | Malignant | |
I18 | 218 | 54 | F | Bladder | High grade invasive urothelial carcinoma | T3bN0M0 | - | IIIA | Malignant | |
I19 | 219 | 33 | M | Bladder | Low grade invasive urothelial carcinoma | T2aN0M0 | - | II | Malignant | |
I20 | 220 | 51 | M | Bladder | Low grade invasive urothelial carcinoma | T3aN2M0 | - | IIIB | Malignant | |
I21 | 221 | 52 | F | Uterus | Endometrial adenocarcinoma | T1aN1M0 | 2 | IIIC1 | Malignant | |
I22 | 222 | 68 | F | Uterus | Endometrial adenocarcinoma | T1bN0M0 | 3 | IB | Malignant | |
I23 | 223 | 35 | F | Uterus | Endometrial adenocarcinoma | T3aN0M0 | 3 | IIIA | Malignant | |
I24 | 224 | 55 | F | Uterus | Endometrial adenocarcinoma | T1bN0M0 | 3 | IB | Malignant | |
I25 | 225 | 58 | F | Uterus | Endometrial adenocarcinoma | T3N1M0 | 3 | IIIC1 | Malignant | |
J1 | 226 | 28 | F | Breast | Breast tissue (fibrofatty tissue) | - | - | - | Normal | |
J2 | 227 | 50 | F | Breast | Breast tissue | - | - | - | Normal | |
J3 | 228 | 42 | F | Breast | Breast tissue | - | - | - | Normal | |
J4 | 229 | 19 | F | Breast | Breast tissue | - | - | - | Normal | |
J5 | 230 | 58 | F | Breast | Breast tissue | - | - | - | Normal | |
J6 | 231 | 40 | M | Testis | Testis tissue | - | - | - | Normal | |
J7 | 232 | 40 | M | Testis | Testis tissue | - | - | - | Normal | |
J8 | 233 | 35 | M | Testis | Testis tissue | - | - | - | Normal | |
J9 | 234 | 30 | M | Testis | Testis tissue | - | - | - | Normal | |
J10 | 235 | 37 | M | Testis | Testis tissue | - | - | - | Normal | |
J11 | 236 | 21 | F | Colon | Colon tissue | - | - | - | Normal | |
J12 | 237 | 23 | M | Colon | Colon tissue | - | - | - | Normal | |
J13 | 238 | 30 | M | Colon | Colon tissue | - | - | - | Normal | |
J14 | 239 | 22 | M | Colon | Colon tissue | - | - | - | Normal | |
J15 | 240 | 40 | M | Colon | Colon tissue | - | - | - | Normal | |
J16 | 241 | 23 | M | Bladder | Bladder tissue | - | - | - | Normal | |
J17 | 242 | 40 | M | Bladder | Bladder tissue | - | - | - | Normal | |
J18 | 243 | 45 | M | Bladder | Bladder tissue | - | - | - | Normal | |
J19 | 244 | 42 | M | Bladder | Bladder tissue | - | - | - | Normal | |
J20 | 245 | 38 | M | Bladder | Bladder tissue | - | - | - | Normal | |
J21 | 246 | 54 | F | Uterus | Endometrial tissue | - | - | - | Normal | |
J22 | 247 | 42 | F | Uterus | Endometrial tissue | - | - | - | Normal | |
J23 | 248 | 27 | F | Uterus | Endometrial tissue | - | - | - | Normal | |
J24 | 249 | 18 | F | Uterus | Endometrial tissue | - | - | - | Normal | |
J25 | 250 | 40 | F | Uterus | Endometrial tissue | - | - | - | Normal | |
K1 | 251 | 36 | F | Thyroid gland | Follicular carcinoma | T3N0M0 | - | I | Malignant | |
K2 | 252 | 68 | F | Thyroid gland | Follicular carcinoma | T3N1M0 | - | III | Malignant | |
K3 | 253 | 63 | F | Chest wall | Metastasis of follicular carcinoma of the thyroid Gland | - | - | - | Metastasis | |
K4 | 254 | 62 | M | Thyroid gland | Follicular carcinoma | T2N0M0 | - | II | Malignant | |
K5 | 255 | 26 | F | Thyroid gland | Follicular carcinoma | T2N0M0 | - | I | Malignant | |
K6 | 256 | 50 | M | Lung | Squamous cell carcinoma | T3aN1M0 | 2 | IIA | Malignant | |
K7 | 257 | 65 | M | Lung | Squamous cell carcinoma | T2aN0M0 | 2 | IB | Malignant | |
K8 | 258 | 52 | M | Lung | Squamous cell carcinoma | T2aN1M0 | 2 | IIA | Malignant | |
K9 | 259 | 36 | M | Lung | Squamous cell carcinoma | T4N0M0 | 2 | IIIA | Malignant | |
K10 | 260 | 59 | M | Lung | Squamous cell carcinoma | T2bN1M0 | 3 | IIB | Malignant | |
K11 | 261 | 45 | M | Tongue | Squamous cell carcinoma | T2N0M0 | 1 | II | Malignant | |
K12 | 262 | 66 | M | Tongue | Squamous cell carcinoma | T2N0M0 | 1 | II | Malignant | |
K13 | 263 | 46 | F | Tongue root | Squamous cell carcinoma | T4aN0M0 | 1 | IVA | Malignant | |
K14 | 264 | 50 | F | Tongue root | Squamous cell carcinoma | T1N0M0 | 2 | I | Malignant | |
K15 | 265 | 61 | M | Tongue | Squamous cell carcinoma | T2N0M0 | 1 | II | Malignant | |
K16 | 266 | 37 | F | Lymph node/Left neck | Hodgkin's lymphoma | - | - | - | Malignant | |
K17 | 267 | 34 | M | Lymph node/Right neck | Hodgkin's lymphoma | - | - | - | Malignant | |
K18 | 268 | 27 | M | Lymph node/Neck | Hodgkin's lymphoma | - | - | - | Malignant | |
K19 | 269 | 17 | M | Lymph node/Right neck | Hodgkin's lymphoma | - | - | - | Malignant | |
K20 | 270 | 32 | M | Lymph node/Neck | Hodgkin's lymphoma | - | - | - | Malignant | |
K21 | 271 | 67 | M | Soft tissue/Buttock | Liposarcoma | T1N0M0 G1 | - | IA | Malignant | |
K22 | 272 | 42 | F | Soft tissue/Thigh | Liposarcoma | T1aN0M0 G1 | - | I | Malignant | |
K23 | 273 | 72 | M | Soft tissue/Thigh | Liposarcoma | T1N0M0 G1 | - | IA | Malignant | |
K24 | 274 | 58 | M | Soft tissue/Thigh | Liposarcoma | T2aN0M0 G1 | IB | Malignant | ||
K25 | 275 | 62 | M | Soft tissue/Back | Liposarcoma | T2aN0M0 G1 | - | IB | Malignant | |
L1 | 276 | 48 | F | Thyroid gland | Follicular carcinoma | T1N0M0 | - | I | Malignant | |
L2 | 277 | 75 | F | Thyroid gland | Follicular carcinoma | T4N0M0 | - | III | Malignant | |
L3 | 278 | 23 | F | Thyroid gland | Papillary carcinoma | T3N0M0 | - | I | Malignant | |
L4 | 279 | 56 | F | Thyroid gland | Papillary carcinoma | T2N0M0 | - | I | Malignant | |
L5 | 280 | 56 | F | Thyroid gland | Papillary carcinoma | T2N0M0 | - | I | Malignant | |
L6 | 281 | 69 | M | Lung | Squamous cell carcinoma | T2aN0M0 | 2 | IB | Malignant | |
L7 | 282 | 35 | F | Lung | Squamous cell carcinoma | T3N1M0 | 3 | IIIA | Malignant | |
L8 | 283 | 64 | M | Lung | Squamous cell carcinoma | T3N1M0 | 3 | IIIA | Malignant | |
L9 | 284 | 63 | F | Lung | Squamous cell carcinoma | T3N1M0 | 3 | IIIA | Malignant | |
L10 | 285 | 51 | F | Lung | Squamous cell carcinoma | T2N1M0 | 3 | IIB | Malignant | |
L11 | 286 | 56 | M | Tongue root | Squamous cell carcinoma | T2N1M0 | 2 | III | Malignant | |
L12 | 287 | 65 | M | Tongue | Squamous cell carcinoma | T3N0M0 | 2 | III | Malignant | |
L13 | 288 | 51 | M | Tongue | Squamous cell carcinoma | T2N0M0 | 2 | II | Malignant | |
L14 | 289 | 68 | F | Right palatine | Squamous cell carcinoma | T2N1M0 | 1 | II | Malignant | |
L15 | 290 | 58 | M | Gingiva | Squamous cell carcinoma | T3N1M0 | 1 | III | Malignant | |
L16 | 291 | 41 | M | Lymph node/Neck | Hodgkin's lymphoma | - | - | - | Malignant | |
L17 | 292 | 24 | M | Lymph node/Neck | Hodgkin's lymphoma | - | - | - | Malignant | |
L18 | 293 | 46 | M | Stomach | Diffuse B cell lymphoma | - | - | - | Malignant | |
L19 | 294 | 45 | M | Lymph node/Left groin | Diffuse B cell lymphoma | - | - | - | Malignant | |
L20 | 295 | 74 | M | Lymph node/Left popliteal fossa | Diffuse B cell lymphoma | - | - | - | Malignant | |
L21 | 296 | 60 | F | Skin/Abdominal cavity | Fibrosarcoma | T2bN0M0 G1 | - | IB | Malignant | |
L22 | 297 | 39 | F | Soft tissue/Leg | Fibrosarcoma | T1aN0M0 G1 | - | IA | Malignant | |
L23 | 298 | 38 | F | Soft tissue/Chest wall | Fibrosarcoma | T1bN0M0 G1 | - | IB | Malignant | |
L24 | 299 | 37 | M | Soft tissue/Leg | Liposarcoma | T3N0M0 G1 | - | IIIB | Malignant | |
L25 | 300 | 63 | M | Soft tissue/Armpit | Myxoid liposarcoma | T2aN0M0 G2 | - | IIB | Malignant | |
M1 | 301 | 28 | F | Thyroid gland | Papillary carcinoma | T2N0M0 | - | I | Malignant | |
M2 | 302 | 30 | F | Thyroid gland | Papillary carcinoma | T3N0M0 | - | I | Malignant | |
M3 | 303 | 33 | F | Thyroid gland | Papillary carcinoma | T1N0M0 | - | I | Malignant | |
M4 | 304 | 25 | M | Thyroid gland | Papillary carcinoma | T1N0M0 | - | I | Malignant | |
M5 | 305 | 26 | F | Thyroid gland | Papillary carcinoma | T2N0M0 | - | I | Malignant | |
M6 | 306 | 54 | M | Lung | Adenocarcinoma | T2aN0M0 | 2 | IB | Malignant | |
M7 | 307 | 55 | M | Lung | Acinar adenocarcinoma | T1N0M0 | 2 | I | Malignant | |
M8 | 308 | 69 | F | Lung | Papillary adenocarcinoma | T4N1M0 | 2 | IIIA | Malignant | |
M9 | 309 | 67 | M | Lung | Solid adenocarcinoma | T4N0M0 | 3 | IIIA | Malignant | |
M10 | 310 | 70 | M | Lung | Solid adenocarcinoma | T1N0M0 | 3 | I | Malignant | |
M11 | 311 | 49 | M | Gingiva | Squamous cell carcinoma | T2N0M0 | 3 | II | Malignant | |
M12 | 312 | 49 | M | Left buccal | Squamous cell carcinoma | T1N0M0 | 2 | I | Malignant | |
M13 | 313 | 70 | M | Buccal | Squamous cell carcinoma | T2N0M0 | 1 | II | Malignant | |
M14 | 314 | 41 | M | Lower lip | Squamous cell carcinoma | T3N0M0 | 2 | III | Malignant | |
M15 | 315 | 66 | M | Right submaxillary | Squamous cell carcinoma | T3N0M0 | 2 | III | Malignant | |
M16 | 316 | 48 | F | Lymph node/Right groin | Diffuse B cell lymphoma | - | - | - | Malignant | |
M17 | 317 | 29 | F | Lymph node/Left armpit | Diffuse B cell lymphoma | - | - | - | Malignant | |
M18 | 318 | 12 | M | Lymph node/Left armpit | Diffuse B cell lymphoma | - | - | - | Malignant | |
M19 | 319 | 61 | M | Lymph node/Right neck | Diffuse B cell lymphoma | - | - | - | Malignant | |
M20 | 320 | 46 | M | Lymph node/Neck | Diffuse B cell lymphoma | - | - | - | Malignant | |
M21 | 321 | 24 | F | Soft tissue/Armpit | Fibrosarcoma | T1N0M0 G2 | - | II | Malignant | |
M22 | 322 | 27 | F | Soft tissue/Abdominal cavity | Fibrosarcoma | T2aN0M0 G2 | - | IIB | Malignant | |
M23 | 323 | 32 | M | Soft tissue/Back | Myxoma | - | - | - | Benign | |
M24 | 324 | 34 | F | Soft tissue/Retroperitoneal cavity | Liposarcoma | T2bN0M0 G2 | - | III | Malignant | |
M25 | 325 | 36 | M | Soft tissue/Chest wall | Fibrosarcoma | T1N0M0 G1 | - | IA | Malignant | |
N1 | 326 | 67 | M | Thyroid gland | Papillary carcinoma | T2N0M0 | - | II | Malignant | |
N2 | 327 | 55 | F | Thyroid gland | Papillary carcinoma | T2N0M0 | - | II | Malignant | |
N3 | 328 | 40 | F | Thyroid gland | Papillary carcinoma | T2N0M0 | - | I | Malignant | |
N4 | 329 | 56 | F | Thyroid gland | Papillary carcinoma | T2N0M0 | - | I | Malignant | |
N5 | 330 | 28 | F | Thyroid gland | Papillary carcinoma | T3N0M0 | - | I | Malignant | |
N6 | 331 | 74 | M | Lung | Acinar adenocarcinoma | T2N0M0 | 3 | IB | Malignant | |
N7 | 332 | 46 | F | Lung | Adenocarcinoma | T2N0M0 | 3 | IB | Malignant | |
N8 | 333 | 68 | M | Lung | Adenocarcinoma | T2N0M0 | 3 | IB | Malignant | |
N9 | 334 | 66 | F | Lung | Adenocarcinoma | T2bN0M0 | 3 | IIA | Malignant | |
N10 | 335 | 58 | M | Lung | Adenocarcinoma | T3N0M0 | 3 | IIB | Malignant | |
N11 | 336 | 68 | M | Salivary gland | Squamous cell carcinoma | T2N1M0 | 2 | III | Malignant | |
N12 | 337 | 53 | M | Maxillary sinus | Squamous cell carcinoma | T2N0M0 | 2 | II | Malignant | |
N13 | 338 | 45 | M | Maxillary sinus | Squamous cell carcinoma | T3N0M0 | 3 | III | Malignant | |
N14 | 339 | 76 | M | Parotid gland | Squamous cell carcinoma | T3N0M0 | 3 | III | Malignant | |
N15 | 340 | 47 | M | Sinuses | Squamous cell carcinoma | T2N0M0 | 2 | II | Malignant | |
N16 | 341 | 63 | F | Lymph node/Left neck | Diffuse B cell lymphoma | - | - | - | Malignant | |
N17 | 342 | 65 | F | Lymph node/Above left collarbone | Diffuse B cell lymphoma | - | - | - | Malignant | |
N18 | 343 | 70 | F | Lymph node/Right neck | Diffuse B cell lymphoma | - | - | - | Malignant | |
N19 | 344 | 44 | M | Lymph node/Right neck | Diffuse large B cell lymphoma | - | - | - | Malignant | |
N20 | 345 | 38 | M | Lymph node/Left neck | Diffuse B cell lymphoma | - | - | - | Malignant | |
N21 | 346 | 25 | F | Waist | Fibrosarcoma | T1bN0M0 G2 | - | IA | Malignant | |
N22 | 347 | 18 | M | Arm | Fibrosarcoma | T1bN0M0 G2 | - | IIB | Malignant | |
N23 | 348 | 60 | M | Waist | Myxoid liposarcoma | T2N0M0 G2 | - | IIIA | Malignant | |
N24 | 349 | 52 | M | Thigh | Fibrosarcoma | T1bN0M0 G3 | - | IIA | Malignant | |
N25 | 350 | 58 | M | Groin | Pleomorphic liposarcoma | T2N0M0 G3 | - | IIIA | Malignant | |
O1 | 351 | 47 | M | Thyroid gland | Thyroid gland tissue | - | - | - | Normal | |
O2 | 352 | 54 | F | Thyroid gland | Thyroid gland tissue | - | - | - | Normal | |
O3 | 353 | 40 | F | Thyroid gland | Thyroid gland tissue | - | - | - | Normal | |
O4 | 354 | 45 | M | Thyroid gland | Thyroid gland tissue | - | - | - | Normal | |
O5 | 355 | 23 | M | Thyroid gland | Thyroid gland tissue | - | - | - | Normal | |
O6 | 356 | 49 | F | Lung | Liung tissue | - | - | - | Normal | |
O7 | 357 | 39 | F | Lung | Liung tissue | - | - | - | Normal | |
O8 | 358 | 23 | M | Lung | Liung tissue | - | - | - | Normal | |
O9 | 359 | 16 | F | Lung | Liung tissue | - | - | - | Normal | |
O10 | 360 | 19 | F | Lung | Liung tissue | - | - | - | Normal | |
O11 | 361 | 21 | M | Skin | Skin tissue | - | - | - | Normal | |
O12 | 362 | 27 | F | Skin | Skin tissue | - | - | - | Normal | |
O13 | 363 | 42 | F | Skin | Skin tissue | - | - | - | Normal | |
O14 | 364 | 33 | M | Skin | Skin tissue | - | - | - | Normal | |
O15 | 365 | 35 | M | Skin | Skin tissue | - | - | - | Normal | |
O16 | 366 | 35 | M | Lymph node | Lymph node tissue | - | - | - | Normal | |
O17 | 367 | 27 | M | Lymph node | Lymph node tissue | - | - | - | Normal | |
O18 | 368 | 32 | M | Lymph node | Lymph node tissue | - | - | - | Normal | |
O19 | 369 | 43 | M | Lymph node | Lymph node tissue | - | - | - | Normal | |
O20 | 370 | 30 | M | Lymph node | Lymph node tissue | - | - | - | Normal | |
O21 | 371 | 54 | F | Skeletal muscle | Skeletal muscle tissue | - | - | - | Normal | |
O22 | 372 | 30 | M | Skeletal muscle | Skeletal muscle tissue | - | - | - | Normal | |
O23 | 373 | 37 | M | Skeletal muscle | Skeletal muscle tissue | - | - | - | Normal | |
O24 | 374 | 33 | M | Skeletal muscle | Skeletal muscle tissue | - | - | - | Normal | |
O25 | 375 | 35 | M | Skeletal muscle | Skeletal muscle tissue | - | - | - | Normal | |
P1 | 376 | 68 | M | Liver | Hepatocellular carcinoma | T2N0M0 | 1 | II | Malignant | |
P2 | 377 | 55 | F | Liver | Hepatocellular carcinoma | T3aN0M0 | 2 | IIIA | Malignant | |
P3 | 378 | 35 | M | Liver | Hepatocellular carcinoma | T2N0M0 | 2 | II | Malignant | |
P4 | 379 | 56 | M | Liver | Hepatocellular carcinoma | T2N0M0 | 2 | II | Malignant | |
P5 | 380 | 56 | M | Liver | Hepatocellular carcinoma | T3N0M0 | 2 | IIIA | Malignant | |
P6 | 381 | 52 | M | Pancreas | Ductal adenocarcinoma | T2N0M0 | 2 | IB | Malignant | |
P7 | 382 | 47 | F | Pancreas | Ductal adenocarcinoma | T3N1M0 | 3 | IIB | Malignant | |
P8 | 383 | 60 | M | Pancreas | Ductal adenocarcinoma | T3N0M0 | 2 | IIB | Malignant | |
P9 | 384 | 64 | M | Pancreas | Adenosquamous carcinoma | T3N0M0 | - | IIA | Malignant | |
P10 | 385 | 56 | M | Pancreas | Ductal adenocarcinoma | T3N1M0 | 2 | IIB | Malignant | |
P11 | 386 | 60 | F | Kidney | Clear cell carcinoma | T2N0M0 | 1 | II | Malignant | |
P12 | 387 | 40 | M | Kidney | Clear cell carcinoma | T1N0M0 | 1 | I | Malignant | |
P13 | 388 | 51 | F | Kidney | Clear cell carcinoma | T2N0M0 | 1 | II | Malignant | |
P14 | 389 | 51 | M | Kidney | Clear cell carcinoma | T2N0M0 | 1 | II | Malignant | |
P15 | 390 | 47 | F | Kidney | Clear cell carcinoma | T2N0M0 | 1 | II | Malignant | |
P16 | 391 | 50 | F | Cervix | Squamous cell carcinoma | T2aN0M0 | 1 | IIA | Malignant | |
P17 | 392 | 56 | F | Cervix | Squamous cell carcinoma | T2aN0M0 | 2 | IIA | Malignant | |
P18 | 393 | 42 | F | Cervix | Squamous cell carcinoma | T1bN0M0 | 1 | IB | Malignant | |
P19 | 394 | 54 | F | Cervix | Squamous cell carcinoma | T2bN0M0 | 2 | IIB | Malignant | |
P20 | 395 | 50 | F | Cervix | Squamous cell carcinoma | T1bN0M0 | 3 | IB | Malignant | |
P21 | 396 | 71 | M | Cardia | Adenocarcinoma | T2N0M0 | 3 | IIA | Malignant | |
P22 | 397 | 62 | M | Esophagus | Adenosquamous carcinoma | T3N0M0 | 2 | IIB | Malignant | |
P23 | 398 | 56 | M | Cardia | Adenocarcinoma | T3N1M0 | 3 | IIIB | Malignant | |
P24 | 399 | 68 | M | Esophagus | Adenocarcinoma | T3N2M0 | 3 | IIIB | Malignant | |
P25 | 400 | 63 | M | Esophagus | Adenocarcinoma | T3N0M0 | 3 | IIB | Malignant | |
Q1 | 401 | 63 | M | Liver | Hepatocellular carcinoma | T3N0M0 | 2 | IIB | Malignant | |
Q2 | 402 | 50 | M | Liver | Hepatocellular carcinoma | T3N0M0 | 2 | IIIA | Malignant | |
Q3 | 403 | 71 | M | Liver | Hepatocellular carcinoma | T3aN0M0 | 2 | IIIA | Malignant | |
Q4 | 404 | 52 | M | Liver | Hepatocellular carcinoma | T3N0M0 | 2 | IIIA | Malignant | |
Q5 | 405 | 49 | M | Liver | Hepatocellular carcinoma | T3aN0M0 | 2 | IIIA | Malignant | |
Q6 | 406 | 64 | M | Pancreas | Ductal adenocarcinoma | T3N0M0 | 2 | IIIA | Malignant | |
Q7 | 407 | 48 | F | Pancreas | Ductal adenocarcinoma | T2N0M0 | 2 | IB | Malignant | |
Q8 | 408 | 42 | F | Pancreas | Ductal adenocarcinoma | T3N0M0 | 1 | IIA | Malignant | |
Q9 | 409 | 42 | M | Pancreas | Ductal adenocarcinoma | T3N0M1 | 2 | IV | Malignant | |
Q10 | 410 | 51 | F | Pancreas | Ductal adenocarcinoma | T3N0M0 | 3 | IIA | Malignant | |
Q11 | 411 | 58 | F | Kidney | Clear cell carcinoma | T1N0M0 | 1 | I | Malignant | |
Q12 | 412 | 62 | M | Kidney | Clear cell carcinoma | T1N0M0 | 1 | I | Malignant | |
Q13 | 413 | 62 | M | Kidney | Clear cell carcinoma | T1N0M0 | 2 | I | Malignant | |
Q14 | 414 | 65 | M | Kidney | Clear cell carcinoma | T2N0M0 | 2 | II | Malignant | |
Q15 | 415 | 72 | F | Kidney | Clear cell carcinoma | T2N0M0 | 2 | II | Malignant | |
Q16 | 416 | 32 | F | Cervix | Squamous cell carcinoma | T1bN0M0 | 2 | IB | Malignant | |
Q17 | 417 | 50 | F | Cervix | Squamous cell carcinoma | T1bN0M0 | 2 | IB | Malignant | |
Q18 | 418 | 44 | F | Cervix | Squamous cell carcinoma | T1bN0M0 | 2 | IB | Malignant | |
Q19 | 419 | 50 | F | Cervix | Squamous cell carcinoma | T1bN0M0 | 2 | IB | Malignant | |
Q20 | 420 | 40 | F | Cervix | Squamous cell carcinoma | T1bN1M0 | 2 | IIIB | Malignant | |
Q21 | 421 | 71 | M | Esophagus | Adenocarcinoma | T3N1M0 | 3 | IIIB | Malignant | |
Q22 | 422 | 65 | M | Esophagus | Adenocarcinoma | T3N2M0 | 3 | IIIB | Malignant | |
Q23 | 423 | 58 | F | Esophagus | Adenocarcinoma | T3N0M0 | 3 | IIB | Malignant | |
Q24 | 424 | 57 | F | Esophagus | Adenocarcinoma | T3N0M0 | 3 | IIA | Malignant | |
Q25 | 425 | 70 | M | Esophagus | Squamous cell carcinoma | T3N1M0 | 3 | IIIB | Malignant | |
R1 | 426 | 38 | M | Liver | Hepatocellular carcinoma | T3N0M0 | 2 | IIIA | Malignant | |
R2 | 427 | 32 | F | Liver | Hepatocellular carcinoma | T3N0M0 | 2 | IIIA | Malignant | |
R3 | 428 | 43 | F | Liver | Hepatocellular carcinoma | T4N0M0 | 2 | IIIC | Malignant | |
R4 | 429 | 48 | M | Liver | Hepatocellular carcinoma | T2N0M0 | 2 | II | Malignant | |
R5 | 430 | 60 | M | Liver | Hepatocellular carcinoma | T3N0M0 | 1 | III | Malignant | |
R6 | 431 | 54 | F | Pancreas | Ductal adenocarcinoma | T3N0M0 | 2 | IIA | Malignant | |
R7 | 432 | 80 | M | Pancreas | Ductal adenocarcinoma | T3N0M0 | 2 | IIA | Malignant | |
R8 | 433 | 61 | F | Pancreas | Ductal adenocarcinoma | T3N0M0 | 2 | IIA | Malignant | |
R9 | 434 | 55 | M | Pancreas | Ductal adenocarcinoma | T3N0M0 | 2 | IIA | Malignant | |
R10 | 435 | 44 | M | Pancreas | Ductal adenocarcinoma | T3N0M0 | 2 | IIA | Malignant | |
R11 | 436 | 70 | M | Kidney | Clear cell carcinoma | T2N1M0 | 2 | III | Malignant | |
R12 | 437 | 67 | F | Kidney | Clear cell carcinoma | T3N0M0 | 2 | III | Malignant | |
R13 | 438 | 59 | M | Kidney | Clear cell carcinoma | T1N0M0 | 2 | I | Malignant | |
R14 | 439 | 69 | M | Kidney | Clear cell carcinoma | T1N0M0 | 2 | I | Malignant | |
R15 | 440 | 80 | M | Kidney | Clear cell carcinoma | T1N0M0 | 2 | I | Malignant | |
R16 | 441 | 41 | F | Cervix | Squamous cell carcinoma | T2N1M0 | 2 | II | Malignant | |
R17 | 442 | 43 | F | Cervix | Squamous cell carcinoma | T1aN0M0 | 2 | IA | Malignant | |
R18 | 443 | 56 | F | Cervix | Squamous cell carcinoma | T1N1M0 | 2 | IIIB | Malignant | |
R19 | 444 | 55 | F | Cervix | Squamous cell carcinoma | T1N0M0 | 2 | I | Malignant | |
R20 | 445 | 37 | F | Cervix | Squamous cell carcinoma | T1N0M0 | 3 | I | Malignant | |
R21 | 446 | 44 | M | Esophagus | Squamous cell carcinoma | T3N1M0 | 2 | IIIB | Malignant | |
R22 | 447 | 58 | M | Esophagus | Squamous cell carcinoma with neuroendocrine differentiation | T3N0M0 | - | IIB | Malignant | |
R23 | 448 | 65 | F | Esophagus | Squamous cell carcinoma | T4N1M0 | 2 | IIIC | Malignant | |
R24 | 449 | 44 | M | Esophagus | Squamous cell carcinoma | T3N1M0 | 2 | IIIB | Malignant | |
R25 | 450 | 48 | M | Esophagus | Squamous cell carcinoma | T3N1M0 | 2 | IIIA | Malignant | |
S1 | 451 | 55 | M | Liver | Hepatocellular carcinoma | T3N0M0 | 3 | IIIA | Malignant | |
S2 | 452 | 42 | F | Liver | Hepatocellular carcinoma | T2N0M0 | 3 | II | Malignant | |
S3 | 453 | 49 | M | Liver | Hepatocellular carcinoma | T2N0M0 | 3 | II | Malignant | |
S4 | 454 | 57 | M | Liver | Hepatocellular carcinoma | T4N0M0 | 3 | IVA | Malignant | |
S5 | 455 | 65 | M | Liver | Adenocarcinoma from gallbladder invasion | T3N0M0 | 3 | IIIA | Malignant | |
S6 | 456 | 55 | M | Pancreas | Ductal adenocarcinoma | T3N0M1 | 3 | IV | Malignant | |
S7 | 457 | 56 | M | Pancreas | Ductal adenocarcinoma with neuroendocrine differentiation | T3N0M0 | 3 | IIA | Malignant | |
S8 | 458 | 23 | F | Pancreas | Adenocarcinoma | T2N0M0 | 3 | IB | Malignant | |
S9 | 459 | 57 | F | Pancreas | Adenocarcinoma | T3N0M0 | 3 | IIA | Malignant | |
S10 | 460 | 62 | F | Pancreas | Adenosquamous carcinoma | T3N0M0 | - | IIA | Malignant | |
S11 | 461 | 54 | M | Kidney | Clear cell carcinoma | T1N0M0 | 2 | I | Malignant | |
S12 | 462 | 82 | M | Kidney | Clear cell carcinoma | T1N0M0 | 2 | I | Malignant | |
S13 | 463 | 43 | M | Kidney | Clear cell carcinoma | T1N0M0 | 3 | I | Malignant | |
S14 | 464 | 33 | F | Kidney | Clear cell carcinoma | T2N0M0 | 3 | II | Malignant | |
S15 | 465 | 49 | M | Kidney | Clear cell carcinoma | T2N0M0 | 3 | II | Malignant | |
S16 | 466 | 42 | F | Cervix | Squamous cell carcinoma | T1N1M0 | 3 | IIIB | Malignant | |
S17 | 467 | 45 | F | Cervix | Squamous cell carcinoma | T1bN0M0 | 3 | IB | Malignant | |
S18 | 468 | 44 | F | Cervix | Squamous cell carcinoma | T2bN0M0 | 3 | IIB | Malignant | |
S19 | 469 | 44 | F | Cervix | Squamous cell carcinoma | T1bN0M0 | 3 | IB | Malignant | |
S20 | 470 | 54 | F | Cervix | Squamous cell carcinoma | T1N0M0 | 3 | I | Malignant | |
S21 | 471 | 66 | M | Esophagus | Squamous cell carcinoma | T3N0M0 | 2 | IIB | Malignant | |
S22 | 472 | 57 | M | Esophagus | Squamous cell carcinoma | T2N0M0 | 2 | IIB | Malignant | |
S23 | 473 | 54 | M | Esophagus | Squamous cell carcinoma | T2N0M0 | 2 | IB | Malignant | |
S24 | 474 | 56 | M | Esophagus | Squamous cell carcinoma | T3N0M0 | 2 | IIA | Malignant | |
S25 | 475 | 57 | M | Esophagus | Adenosquamous carcinoma | T4N0M0 | 3 | IIIB | Malignant | |
T1 | 476 | 35 | M | Liver | Liver tissue | - | - | - | Normal | |
T2 | 477 | 43 | M | Liver | Liver tissue | - | - | - | Normal | |
T3 | 478 | 40 | M | Liver | Liver tissue | - | - | - | Normal | |
T4 | 479 | 23 | M | Liver | Liver tissue | - | - | - | Normal | |
T5 | 480 | 50 | M | Liver | Liver tissue | - | - | - | Normal | |
T6 | 481 | 49 | F | Pancreas | Pancreas tissue | - | - | - | Normal | |
T7 | 482 | 39 | F | Pancreas | Pancreas tissue | - | - | - | Normal | |
T8 | 483 | 28 | F | Pancreas | Pancreas tissue | - | - | - | Normal | |
T9 | 484 | 40 | M | Pancreas | Pancreas tissue | - | - | - | Normal | |
T10 | 485 | 2 | F | Pancreas | Pancreas tissue | - | - | - | Normal | |
T11 | 486 | 54 | F | Kidney | Kidney tissue | - | - | - | Normal | |
T12 | 487 | 23 | M | Kidney | Kidney tissue | - | - | - | Normal | |
T13 | 488 | 28 | F | Kidney | Kidney tissue | - | - | - | Normal | |
T14 | 489 | 27 | M | Kidney | Kidney tissue | - | - | - | Normal | |
T15 | 490 | 2 | F | Kidney | Kidney tissue | - | - | - | Normal | |
T16 | 491 | 54 | F | Cervix | Cervical canal tissue | - | - | - | Normal | |
T17 | 492 | 49 | F | Cervix | Cervical tissue | - | - | - | Normal | |
T18 | 493 | 34 | F | Cervix | Cervical tissue | - | - | - | Normal | |
T19 | 494 | 50 | F | Cervix | Cervical canal tissue | - | - | - | Normal | |
T20 | 495 | 37 | F | Cervix | Cervical canal tissue | - | - | - | Normal | |
T21 | 496 | 39 | F | Esophagus | Esophageal tissue | - | - | - | Normal | |
T22 | 497 | 54 | F | Esophagus | Esophageal tissue | - | - | - | Normal | |
T23 | 498 | 45 | M | Esophagus | Esophageal tissue | - | - | - | Normal | |
T24 | 499 | 23 | M | Esophagus | Esophageal tissue | - | - | - | Normal | |
T25 | 500 | 35 | M | Esophagus | Esophageal tissue | - | - | - | Normal | |
- | 0 | 42 | M | Adrenal gland | Pheochromocytoma (tissue marker) | - | Malignant |
Find overlapping cases with this tissue array:
- Product Code: MC5004b
- Availability: Out Of Stock